Ren Lab
Dr. Ren leads the research and operational activities of the NYGC, which focus on the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative diseases, and neuropsychiatric diseases. He also directs NYGC’s faculty, who lead independent research labs based at the Center. A pioneer in epigenomics, Dr. Bing Ren has made foundational discoveries in gene regulation, including mapping millions of regulatory elements, uncovering chromatin organization principles, and interpreting non-coding disease variants.
Bing Ren, PhD
Scientific Director and CEO, NYGC
Professor of Genetics and Development, Biochemistry and Molecular Biophysics, and Systems Biology, Associate Director in the Vagelos Institute for Basic Biomedical Science (Vagelos Institute) in VP&S, Columbia University

Latest News & Publications
Highlights from Dr. Ren's Previous Work
-
Science · 2023 October 13.
A comparative atlas of single-cell chromatin accessibility in the human brain.
-
Cell · 2021 November 24.
A single-cell atlas of chromatin accessibility in the human genome.
-
Nature · 2012 April 11.
Topological domains in mammalian genomes identified by analysis of chromatin interactions.
-
Nature Genetics · 2007 February 4.
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.